Cigna Healthcare has appointed Stanley Crittenden, MD, as its new chief medical officer. The company announced the decision in a March 23 news release. This marks a significant leadership move for Cigna’s health benefits division.
Cigna Healthcare Appoints Dr. Stanley Crittenden as CMO
Cigna Healthcare — the health benefits arm of The Cigna Group — has tapped an experienced physician executive to lead its clinical direction. Dr. Crittenden steps into the CMO role with a strong background in payer-side healthcare leadership. Furthermore, his appointment reflects Cigna’s continued focus on strengthening its clinical operations.
The decision comes as Cigna works to improve care access and simplify the overall healthcare experience for its members. Consequently, Dr. Crittenden’s clinical expertise positions him well to drive these goals forward.
Who Is Dr. Stanley Crittenden?
Dr. Crittenden is a board-certified physician executive with deep expertise across multiple clinical disciplines. Specifically, he holds certifications in internal medicine, nephrology, and clinical hypertension. These specializations give him a well-rounded perspective on managing complex patient populations.
Academic and Clinical Credentials
Dr. Crittenden’s board certifications span three distinct areas of medicine. Internal medicine provides a broad clinical foundation. Nephrology brings specialized knowledge of kidney-related conditions. Additionally, clinical hypertension expertise supports focus on one of America’s most prevalent chronic conditions. Together, these credentials equip him to lead Cigna’s clinical strategy with precision.
His Role and Responsibilities at Cigna Healthcare
As CMO, Dr. Crittenden will oversee all of Cigna Healthcare’s clinical initiatives. He will also collaborate directly with senior leaders across The Cigna Group. Together, they will work to expand care access and ease the healthcare experience for members.
Moreover, his position places him at the center of Cigna’s efforts to connect clinical strategy with business outcomes. This alignment is increasingly important as payers face growing pressure to deliver value-based, patient-centered care.
Improving Access and Simplifying Healthcare
Cigna Healthcare has consistently prioritized removing barriers to care. Dr. Crittenden’s clinical background supports that mission directly. He is expected to bring a data-informed, patient-focused lens to these initiatives. As a result, members may see improvements in how they navigate their benefits and access treatment.
Previous Leadership at Quantum Health, Anthem, and Humana
Before joining Cigna, Dr. Crittenden served as CMO at Quantum Health, a care navigation company. There, he guided clinical strategy for a company dedicated to helping employees understand and use their benefits more effectively.
Prior to Quantum Health, he also held leadership roles at Anthem and Humana — two of the nation’s largest health insurers. This breadth of experience across top-tier payer organizations makes him a seasoned leader in the managed care space.
A Track Record Across Major Payers
Working at Anthem and Humana gave Dr. Crittenden exposure to large-scale clinical operations. He understands how major payers balance cost management with quality care delivery. Therefore, he brings both strategic and operational insight to his new role at Cigna Healthcare.
Amy Flaster’s Transition to a Broader Cigna Group Role
Dr. Crittenden’s appointment fills the vacancy created when Amy Flaster, MD, moved into an expanded position. In November, Cigna promoted Dr. Flaster from her CMO role at Cigna Healthcare to serve The Cigna Group in a broader capacity. She had originally joined Cigna in 2024 from ConcertoCare, a home-care provider.
Her elevation reflects how Cigna continues to develop clinical talent internally. Meanwhile, the search for her successor led to Dr. Crittenden, whose payer experience aligns with the company’s strategic priorities.
What This Appointment Means for Cigna’s Clinical Future
This leadership change signals Cigna Healthcare’s commitment to elevating clinical oversight at the highest level. Dr. Crittenden brings fresh perspective from outside the organization, combined with deep institutional knowledge of the payer industry.
As healthcare continues to evolve rapidly, having a seasoned CMO is essential. Cigna Healthcare’s decision to appoint Dr. Crittenden suggests the company is prioritizing clinical excellence, member access, and cross-functional collaboration as its core strategic pillars moving forward.
